de Ribamar Costa, José <br/><br/>
One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials.  [electronic resource] 

 -  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology  Nov 2016 
 - 1255-1262 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1969-6213 
<br/><br/><label>Standard No.: </label>10.4244/EIJV12I10A206  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorbable Implants<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angioplasty, Balloon, Coronary--methods<br/>Cardiovascular Agents--administration & dosage<br/>Drug-Eluting Stents<br/>Everolimus--therapeutic use<br/>Female<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Metals<br/>Middle Aged<br/>Myocardial Infarction--therapy<br/>Propensity Score<br/>Prospective Studies<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome